400
Views
10
CrossRef citations to date
0
Altmetric
Letter

Lenalidomide: a new treatment option for Castleman disease

, , , , , , , , , , & show all
Pages 2089-2091 | Received 17 Jul 2011, Accepted 04 Sep 2011, Published online: 05 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kah-Lok Chan, Stephen Lade, H Miles Prince & Simon J Harrison. (2016) Update and new approaches in the treatment of Castleman disease. Journal of Blood Medicine 7, pages 145-158.
Read now

Articles from other publishers (9)

Zdeněk Adam, Zdeněk Řehák, Zuzana Adamová, Renata Koukalová, Luděk Pour, Marta Krejčí, Ivanna Boichuk, Viera Sandecká, Martin Krejčí, Martin Štork, Sabina Ševčíková & Zdeněk Král. (2022) Multicentric Castleman's disease. Symptoms, diagnostics and therapy. Vnitřní lékařství 68:1, pages 41-53.
Crossref
Tomoki Suichi, Sonoko Misawa, Yukari Sekiguchi, Kazumoto Shibuya, Atsuko Tsuneyama, Yo-ichi Suzuki, Keigo Nakamura, Hiroki Kano & Satoshi Kuwabara. (2020) Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease. Journal of the Neurological Sciences 413, pages 116771.
Crossref
Yi Zhang, Shan-Shan Suo, Han-Jin Yang, Xin-Ping Zhou, Liang-Shun You, Wen-Juan Yu, Zhao-Ming Wang & Jie Jin. (2020) Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study. Journal of Cancer Research and Clinical Oncology 146:2, pages 357-365.
Crossref
Sisi Cai, Zhaodong Zhong, Xiang Li, Hong Xiang Wang, Li Wang & Min Zhang. (2019) Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids. Medicine 98:46, pages e17681.
Crossref
Xinping Zhou, Juying Wei, Yinjun Lou, Gaixiang Xu, Min Yang, Hui Liu, Liping Mao, Hongyan Tong & Jie Jin. (2017) Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases. Frontiers of Medicine 11:2, pages 287-292.
Crossref
A. González García, M.Á. Moreno Cobo & J.L. Patier de la Peña. (2016) Current diagnosis and treatment of Castleman's disease. Revista Clínica Española (English Edition) 216:3, pages 146-156.
Crossref
A. González García, M.Á. Moreno Cobo & J.L. Patier de la Peña. (2016) Diagnóstico y tratamiento actual de la enfermedad de Castleman. Revista Clínica Española 216:3, pages 146-156.
Crossref
Yujun Dong, Mingyue Wang, Lin Nong, Lihong Wang, Xinan Cen, Wei Liu, Sainan Zhu, Yuhua Sun, Zeyin Liang, Yuan Li, Jinping Ou, Zhixiang Qiu & Hanyun Ren. (2015) Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor. British Journal of Haematology 169:6, pages 834-842.
Crossref
Petr Szturz, Zdenek Adam, Zdenek Rehak, Renata Koukalova, Leos Kren, Mojmír Moulis, Marta Krejcí & Jiri Mayer. (2018) Salvage lenalidomide in four rare oncological diseases. Tumori Journal 99:5, pages e251-e256.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.